RxDoctor Payments DataLook up a doctor →

Laura Gillespie

Physician Assistant · Atlanta, GANPI 1659970408

Payments from drug & device makers

$19,247in general payments, 2019–2025

Across 790 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tandem Diabetes Care, Inc.$2K
  • Novo Nordisk$2K
  • Sanofi-aventis U.S. LLC$2K
  • Lilly USA, LLC$1K
  • Abbott$1K
  • Corcept Therapeutics$968
  • plus $10K from 44 others

What the payments were for

  • Consulting fees$9605%
  • Travel & lodging$1,0946%
  • Food & beverage$17,16889%
  • Education$260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,247 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide177$292,268
MounjaroTirzepatide100$164,442
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/766$83,092
JardianceEmpagliflozin54$79,510
TrulicityDulaglutide39$45,839
RybelsusSemaglutide24$45,557
JanuviaSitagliptin Phosphate34$43,958
FarxigaDapagliflozin Propanediol37$42,073
Tresiba Flextouch U-100Insulin Degludec57$41,328
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt14$26,087
FiaspInsulin Aspart (Niacinamide)14$25,538
NovologInsulin Aspart56$19,722
Soliqua 100-33Insulin Glargine/Lixisenatide11$17,567
Tresiba Flextouch U-200Insulin Degludec21$15,062
Humalog Kwikpen U-100Insulin Lispro61$14,985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Fiasp, Novolog$1,935$383,085271 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro$1,316$222,283184 claims
Boehringer IngelheimJardiance$499$79,51054 claims
MerckJanuvia$151$43,95834 claims
AstraZenecaFarxiga$427$42,07337 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$1,886$17,56711 claims
AbbVieSynthroid, Armour Thyroid$284$3,40135 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$435$1,657147 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →